{
    "2021-04-29": [
        [
            {
                "time": "",
                "original_text": "年报里的医药增长密码：集采疫情内外因素跌宕 创新药时代来临18家药企研发增超100%",
                "features": {
                    "keywords": [
                        "医药",
                        "集采",
                        "疫情",
                        "创新药",
                        "研发"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药(600276.SH)：注射用卡瑞利珠单抗获得美国FDA孤儿药资格认定",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "FDA",
                        "孤儿药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2000亿医药主题基金短线榜单 葛兰、赵蓓、吴兴武谁的基金一季度扛住了？",
                "features": {
                    "keywords": [
                        "医药基金",
                        "葛兰",
                        "赵蓓",
                        "吴兴武",
                        "一季度"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：注射用卡瑞利珠单抗获得美国FDA孤儿药资格认定",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "FDA",
                        "孤儿药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药今日大宗交易成交270万股，成交价79.55元折价3.4%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "折价"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "高瓴、爱尔齐押注的兆科眼科，能否留住光环",
                "features": {
                    "keywords": [
                        "高瓴",
                        "爱尔",
                        "兆科眼科"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2022-04-28",
                "original_text": "A股融资融券日报：两融余额增加19.61亿元（4月28日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "A股",
                        "融资融券"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创新药的焦虑时刻：3成初创药企股价破发、近百个临床项目围剿热门靶点 连续下跌",
                "features": {
                    "keywords": [
                        "创新药",
                        "股价破发",
                        "临床项目",
                        "热门靶点"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "财信证券基金行业点评：主动权益型基金21年1季报持仓分析",
                "features": {
                    "keywords": [
                        "财信证券",
                        "基金",
                        "主动权益型",
                        "持仓分析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}